國家衛生研究院 NHRI:Item 3990099045/16205
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 908734      Online Users : 1035
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/16205


    Title: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients response
    Authors: Wu, TY;Chen, PY;Wang, JT;Liu, WD;Chen, YC;Chang, SC
    Contributors: National Institute of Infectious Diseases and Vaccinology
    Date: 2024-10-07
    Relation: Journal of Antimicrobial Chemotherapy. 2024 Oct 07;Article in Press.
    Link to: http://dx.doi.org/10.1093/jac/dkae357
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0305-7453&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001330221900001
    Appears in Collections:[Yee-Chun Chen] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    ISI001330221900001.pdf153KbAdobe PDF11View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback